Light Horse Therapeutics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $62M
Investors
- 5
About Light Horse Therapeutics
Based in California, US, Light Horse Therapeutics Inc. operates as a biotechnology research company that develops gene editing platforms essential for drug discovery, primarily in the field of oncology. The firm was cofounded in 2020 by Brian Liau, Ben Cravatt, and Nathaniel Gray. In January 2025, Light Horse Therapeutics Inc. The company's core product offerings focus on identifying cryptic, chemically accessible functional domains within protein targets that contribute to the progression of disabling and life-threatening diseases. This advanced platform systematically analyzes complex signaling pathways, particularly in oncology, to uncover novel therapeutic targets. By interrogating these targets within their native cellular context, Light Horse ensures that laboratory discoveries are effectively translated into clinical applications. Light Horse Therapeutics operates on a revenue model encompassing strategic partnerships and collaborations with major pharmaceutical companies.
Who invested in Light Horse Therapeutics
5 investors across 1 round
See all investors in Light Horse Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 9, 2025
Amount
$62M
Investors
Questions about Light Horse Therapeutics
Who invested in Light Horse Therapeutics?
Light Horse Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Light Horse Therapeutics raised?
Light Horse Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Light Horse Therapeutics last raise money?
Light Horse Therapeutics's most recent round on record is a Series A, in Jan 2025.
What does Light Horse Therapeutics do?
Based in California, US, Light Horse Therapeutics Inc.
Where is Light Horse Therapeutics headquartered?
Light Horse Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Light Horse Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Light Horse Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Light Horse Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.